“Lose weight just by taking an injection” — this is the catchphrase that has made the GLP-1/GIP receptor agonist Mounjaro injection (Mounjaro®; generic name: tirzepatide) a hot topic. It was originally developed as a treatment for type 2 diabetes, but its strong weight-loss effect was demonstrated in clinical trials, and it has also been approved as an obesity treatment in other countries.
In Japan it is approved only as a diabetes treatment, yet its use for medical weight loss as self-pay treatment is spreading rapidly. This article explains in expert detail Mounjaro’s mechanism of action, clinical data, side effects, safe use, the situation in Japan and overseas, and costs.
The short answerBusy? Just read this part
- Mounjaro is the world’s first dual receptor agonist, acting on two hormone receptors, GLP-1 and GIP, at the same time
- In large clinical trials, Mounjaro showed greater weight loss than conventional GLP-1 medications
- Mounjaro is highly effective, but in exchange it requires an understanding of side-effect management and costs
What you will learn in this article
- How Mounjaro (tirzepatide) differs from GLP-1 medications, and its mechanism of action as a GIP/GLP-1 dual receptor agonist
- The weight loss seen in the SURMOUNT-1 trial, and the proportion of people who lost 10%, 15% and 20% or more of their body weight
- How the dose is increased (a gradual escalation schedule starting at 2.5 mg) and how to deal with side effects
- The fact that in Japan it is approved only as a diabetes treatment, so use for weight loss is self-pay treatment
- Actual prices for Hiro Clinic medical weight loss (official prices as of July 2026)
1. What is the Mounjaro injection?
Mounjaro is the world’s first dual receptor agonist, acting on two hormone receptors, GLP-1 and GIP, at the same time. Mounjaro (generic name: tirzepatide) is a new type of diabetes medication approved by the U.S. FDA (Food and Drug Administration) in 2022. Its key feature is that, in addition to the action of the GLP-1 receptor agonists used until now (e.g. Ozempic, Rybelsus), it also acts on the GIP receptor. For this reason it is called a GLP-1/GIP dual receptor agonist.
Conventional GLP-1 medications have attracted attention for effects such as suppressing appetite, slowing the stomach to keep you feeling full, and helping insulin secretion. Mounjaro, by adding the action of GIP, is thought to improve metabolism more broadly.
Two points of action
- GLP-1 action
• Acts on the appetite center in the brain to suppress appetite
• Slows the emptying of stomach contents, keeping you feeling full for longer
• Promotes insulin secretion from the pancreas when blood sugar rises - GIP action
• Further strengthens insulin secretion in the pancreas
• Helps muscle and fat tissue take up sugar efficiently and use it as energy
• Improves overall metabolism and balances energy use and expenditure
Mounjaro’s strength is that this dual action achieves both blood sugar control and weight loss. Because it does not simply suppress appetite but works to rebuild the body’s metabolism from the ground up, it is expected to produce stronger weight loss and greater improvement in lifestyle-related disease risks than conventional GLP-1 medications.
2. Effects as a medical weight-loss treatment
2-1. Clinical trial results
In large clinical trials, Mounjaro showed greater weight loss than conventional GLP-1 medications. The best illustration of Mounjaro’s effect is the internationally watched SURMOUNT-1 trial. When the drug was given to patients with obesity for 72 weeks (about a year and a half), the following weight loss was seen.
- 5 mg group: average −15.0%
- 10 mg group: average −19.5%
- 15 mg group: average −20.9%
For example, for a person weighing 100 kg, this works out to an expected weight loss of about 20 kg or more on the 15 mg dose. This far exceeds the weight-loss rate (about 5–7%) achieved through lifestyle changes such as diet and exercise alone.
Among the trial’s secondary endpoints, results were also published grouped by the amount of weight lost. The proportion of people who lost 10% or more of their body weight reached 73% in the 5 mg group, 86% in the 10 mg group and 90% in the 15 mg group (14% in the placebo group). In addition, the proportion who lost 20% or more of their body weight was reported as 32% in the 5 mg group, 55% in the 10 mg group and 63% in the 15 mg group (1.3% in the placebo group). These figures show a tendency for the proportion of people achieving substantial weight loss to increase as the dose rises. However, results vary from person to person, and please note that not everyone will get the same result.
Because of data like this, Mounjaro has become a worldwide talking point as a drug that is rewriting the conventional wisdom about weight loss with medication.
2-2. Metabolic improvements
Mounjaro’s benefits are not limited to weight loss. The following metabolic improvements have also been seen with treatment.
- Improved fasting blood sugar and lower HbA1c (an indicator of blood sugar control)
- Lower triglycerides and LDL (“bad”) cholesterol
- A tendency toward improved blood pressure
In other words, a major attraction is that it not only helps you lose weight but may also lower the risk of lifestyle-related diseases such as diabetes, high cholesterol and high blood pressure.
3. The mechanism of action in detail
Mounjaro’s weight-loss effect comes from a combined mechanism in which several hormone actions work at the same time. Mounjaro’s weight-loss effect is not as simple as a drug that “suppresses appetite”. By acting on several of the body’s systems at once, it creates a state in which it is easier to lose weight.
- Action on the brain’s appetite center
GLP-1 and GIP act on the brain so that appetite is naturally suppressed. Because the urge to eat itself becomes weaker, you can reduce calorie intake without forcing yourself to hold back. - Delayed gastric emptying
It slows the speed at which food passes from the stomach to the small intestine, so the feeling of fullness lasts longer. This makes it easier to feel satisfied with smaller amounts and to avoid snacking and overeating. - Stabilized blood sugar
By suppressing sharp rises in blood sugar (blood sugar spikes), it makes fat less likely to be stored in the body. It also reduces the hunger caused by blood sugar swings, which helps curb unnecessary appetite. - Promotion of fat metabolism
It increases sugar use in muscle and fat tissue, leading the body toward a state in which excess fat is burned more easily. Because energy efficiency itself improves, it also helps build a body that is less prone to regaining weight.
Through this combination of actions — appetite suppression, sustained fullness, blood sugar stabilization and metabolic improvement — Mounjaro produces greater weight loss than earlier drugs.
4. How it is given and the treatment schedule
Mounjaro is a once-weekly self-injection, and the standard treatment schedule starts at a low 2.5 mg dose and increases step by step. The Mounjaro injection is basically used as a once-weekly subcutaneous injection. Because it uses an injection pen for self-injection, you can give it to yourself at home after receiving instructions at the clinic.
- Starting dose
Treatment starts at 2.5 mg/week. Starting suddenly at a high dose tends to cause strong side effects (nausea and diarrhea), so you start at a low dose and let your body get used to it. - Dose escalation
Every few weeks the dose is raised step by step
→ 5 mg
→ 7.5 mg
→ 10 mg
…and so on. Up to 15 mg/week can be used, but the doctor always adjusts the dose while checking the patient’s condition and response. - Treatment period
Weight starts to fall even over a short period, but continuing for 3–6 months or longer is recommended for a stable effect. - Combining with lifestyle habits
Rather than relying on the medication alone, combining it with nutritional guidance and exercise is the key to getting the most out of it. In particular, eating with attention to protein and adding light strength training can help you reduce fat while maintaining muscle.

Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
5. Side effects and safety
Mounjaro commonly causes digestive symptoms such as nausea and diarrhea, so using it under a doctor’s supervision while adjusting the dose is a prerequisite for continuing it safely. While the Mounjaro injection is highly effective, side effects have also been reported. They are especially likely in the early stage and when the dose is increased, so it is important to use it while consulting your doctor.
5-1. Common side effects
- Digestive symptoms: nausea, diarrhea, constipation, stomach discomfort
- Loss of appetite: appetite may drop so much that you do not get enough of the nutrients you need
- Injection-site reactions: redness or swelling of the skin
→ In many cases these ease as your body gets used to the medication with continued use. Nausea in particular is the most common symptom in the early stage.
5-2. Serious side effects (rare)
- Acute pancreatitis: if you have severe abdominal pain or back pain, you need to see a doctor right away.
- Hypoglycemia: more likely especially when used together with other diabetes medications.
- Risk of medullary thyroid cancer: reported in animal studies, but it is not clear whether it occurs in humans.
→ These occur very rarely, but they can be dangerous if left untreated, so caution is needed.
5-3. People who need to be careful
- People who are pregnant or breastfeeding
- People with severe gastrointestinal disease (because the movement of the digestive tract is easily affected)
- People who have had pancreatitis in the past
→ For these people, use should in principle be avoided, or a careful decision is needed.
6. Approval status in Japan and overseas
In the U.S. and the EU, Mounjaro is also approved as an obesity treatment, but in Japan it is currently approved only as a diabetes treatment. The scope of approval for the Mounjaro injection differs from country to country.
U.S. and EU
- Approved as a treatment for type 2 diabetes
- Also already approved as an obesity treatment
- Obesity is regarded as a chronic disease that raises the risk of diabetes and heart disease, and drug treatment is actively used.
Japan
- Currently approved only as a diabetes treatment
- Use for obesity is not approved, so if it is used for that purpose it is self-pay treatment (paid out of pocket).
- In Japan, the view that obesity should be addressed by improving lifestyle habits remains strong, and drug treatment is still only a supplementary option.
Differences in background
- Overseas: a trend toward actively treating obesity as a disease, with the aim of preventing diabetes and heart disease.
- Japan: a tendency to prioritize improvement through diet and exercise first and to use drug treatment only in limited cases.
→ For this reason, if you want Mounjaro as an obesity treatment in Japan, please note that it is not covered by health insurance and tends to be expensive.
7. Approximate costs (self-pay treatment in Japan)
When Mounjaro is used for weight loss, it is self-pay treatment paid entirely by the patient, and our clinic shows the price for each dose on our official website. When the Mounjaro injection is used for weight loss, health insurance does not apply in Japan, so the full cost is paid by the patient (self-pay treatment).
The main approximate costs are as follows.
- First visit and test fees: about ¥5,000–10,000
(may include blood tests, body composition measurement, etc.) - Medication cost: about ¥30,000–60,000 per month
(varies with the pen strength and dose) - Other costs: nutritional guidance and regular blood tests may be required separately
When used to treat diabetes, it may be covered by health insurance, but for obesity or weight loss the full cost is self-paid. For this reason, if you plan to continue long term, it is important to check the costs carefully in advance.
Hiro Clinic medical weight-loss prices (as of July 2026)
For those who want to know the actual amounts rather than estimates, we have summarized our clinic’s official prices by dose. Prices may be revised, so please always check the latest price list page before signing up.
| Dose | Contents | Regular price (tax incl.) |
|---|---|---|
| 2.5mg | 1 pen | ¥4,400 |
| 5mg | 1 pen | ¥6,480 |
| 7.5mg | 1 pen | ¥15,400 |
*The Japanese original is authoritative.
If you use our discounted subscription delivery (shipping fee ¥660), which assumes continued use, 2.5 mg and 5 mg become even cheaper. Because Mounjaro starts at 2.5 mg/week, the medication cost in the first month starts at about ¥17,600 (based on 4 injections a month), and after dose escalation the cost rises according to the dose. First-visit and blood test fees may also be charged separately.
Summary
Mounjaro is highly effective, but in exchange it requires an understanding of side-effect management and costs. The Mounjaro injection is a new-generation medical weight-loss drug with a weight-loss effect exceeding that of conventional GLP-1 medications. Overseas it is also approved as an obesity treatment, and its efficacy has been shown in clinical trials.
On the other hand, in Japan it is still approved only as a diabetes treatment, and use for obesity is self-pay treatment. There are also issues such as side effects and cost, so it is essential to use it safely under a doctor’s supervision rather than on your own judgment.
Rather than making “losing weight quickly” your goal, it is best used as a support tool for maintaining your health over the long term in combination with lifestyle improvements. The Mounjaro injection is one strong option for this purpose.
What matters even more is not relying on the medication alone, but improving your diet, exercise and lifestyle habits in ways that suit you at the same time. Doing so helps prevent regaining weight and lets you truly “lose weight and become healthy”. Mounjaro can be a powerful ally that helps you take that first step.
About self-pay treatment and off-label use
Frequently asked questions (FAQ)
We have compiled questions patients often ask about Mounjaro, with answers. Here are questions often asked by people considering the Mounjaro injection. Whether it is suitable depends on your individual symptoms and constitution, so please always consult a doctor at a consultation for the final decision.
QHow long does it take to notice the effects of Mounjaro?
Results vary, but in the SURMOUNT-1 trial, changes in body weight began to appear within a few weeks of starting treatment, and substantial effects were seen with 72 weeks (about 1 year and 4–5 months) of continued use. Rather than aiming for rapid weight loss in a short time, it is important to review your progress over several months together with your doctor.
QDoes the Mounjaro injection hurt?
The injection pen is designed with a thin needle, and many people find it causes little pain. However, redness or swelling may occur at the injection site, so it is recommended to rotate sites rather than using the same spot every time.
QHow is Mounjaro different from conventional GLP-1 medications such as Ozempic?
Ozempic and Rybelsus act only on the GLP-1 receptor, whereas Mounjaro is a dual receptor agonist that acts on the GIP receptor in addition to GLP-1. The SURMOUNT-1 trial reported results exceeding the typical weight-loss rate of GLP-1-only medications, but how well it works varies from person to person, and for quite a few people a GLP-1-only medication may suit them better depending on their constitution.
QIs there anyone who cannot use Mounjaro?
People who are pregnant or breastfeeding, people with severe gastrointestinal disease, and people who have had pancreatitis in the past should in principle avoid it, or a careful decision is needed. For people with a medical history, the doctor decides whether it is suitable after a consultation and blood tests beforehand.
QIs Mounjaro covered by health insurance?
When used to treat type 2 diabetes, it may be covered by health insurance, but use for obesity or weight loss is self-pay treatment not covered by health insurance, and the full cost is paid by the patient. You can check our clinic’s prices on the official price list page.
QWill I regain weight if I stop?
The appetite-suppressing effect of the medication gradually wears off after you stop, so it is thought that weight tends to return if you have not also improved your lifestyle habits. Our clinic provides follow-up support, including nutritional guidance, to help you maintain your weight even after treatment ends.
Who to contact about side effects | When to see a doctor
If you have any of the following symptoms, please contact us instead of waiting to see how things go on your own. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly digestive symptoms. Most are mild, but serious ones occasionally occur.
| Symptoms | Possible cause | What to do |
|---|---|---|
| Ongoing nausea and vomiting | Digestive symptoms. The most common side effect | Please contact us if you remain unable to keep fluids down |
| Severe abdominal pain (pain that goes through to the back) | Possible acute pancreatitis | Stop the medication immediately and see a doctor |
| Cold sweats, palpitations, intense hunger, clouded consciousness | Hypoglycemia | Take sugar right away and contact us |
| Skin rash, difficulty breathing, swelling of the face or throat | Allergic reaction | See a doctor immediately |
Contact: 0120-241-929 (hours 9:00–18:00)
If your symptoms are severe outside these hours, please go to your nearest emergency medical facility.
Direct phone numbers for each clinic are listed on the clinic information page.
References
The information on medications in this article is based on the following official sources. For details on dosage and administration and side effects, always check the latest electronic package insert.
Pharmaceuticals and Medical Devices Agency (PMDA): Mounjaro Subcutaneous Injection Ateos, electronic package insert
PMDA: Drug Guide for Patients, Mounjaro Subcutaneous Injection Ateos (PDF)
Ministry of Health, Labour and Welfare: Prevention of lifestyle-related diseases
When Mounjaro is used for purposes other than obesity disease, it is self-pay treatment and public health insurance does not apply. Effects and side effects vary from person to person.



